Research in the field of cancer aggregation is rapidly progressing. Advances in imaging techniques and molecular biology are providing new insights into the dynamics of cell aggregation and its role in cancer. Studies are also focusing on identifying biomarkers that can predict the propensity of tumors to aggregate, which can aid in personalized treatment approaches. Additionally, preclinical and clinical trials are evaluating the efficacy of drugs targeting aggregation pathways, showing promising results.
